chr1-65063072-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001321852.2(JAK1):​c.-78+4532A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.14 in 152,232 control chromosomes in the GnomAD database, including 1,784 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.14 ( 1784 hom., cov: 32)

Consequence

JAK1
NM_001321852.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -4.40

Publications

4 publications found
Variant links:
Genes affected
JAK1 (HGNC:6190): (Janus kinase 1) This gene encodes a membrane protein that is a member of a class of protein-tyrosine kinases (PTK) characterized by the presence of a second phosphotransferase-related domain immediately N-terminal to the PTK domain. The encoded kinase phosphorylates STAT proteins (signal transducers and activators of transcription) and plays a key role in interferon-alpha/beta, interferon-gamma, and cytokine signal transduction. This gene plays a crucial role in effecting the expression of genes that mediate inflammation, epithelial remodeling, and metastatic cancer progression. This gene is a key component of the interleukin-6 (IL-6)/JAK1/STAT3 immune and inflammation response and is a therapeutic target for alleviating cytokine storms. The kinase activity of this gene is directly inhibited by the suppressor of cytokine signalling 1 (SOCS1) protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2020]
JAK1 Gene-Disease associations (from GenCC):
  • autoinflammation, immune dysregulation, and eosinophilia
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.288 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001321852.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK1
NM_001321852.2
c.-78+4532A>G
intron
N/ANP_001308781.1P23458
JAK1
NM_001321853.2
c.-162+3556A>G
intron
N/ANP_001308782.1P23458
JAK1
NM_001321854.2
c.-78+3556A>G
intron
N/ANP_001308783.1P23458

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK1
ENST00000671954.2
c.-181+4532A>G
intron
N/AENSP00000500841.1P23458
JAK1
ENST00000672434.2
c.-162+3556A>G
intron
N/AENSP00000499900.1P23458
JAK1
ENST00000672751.2
c.-78+4532A>G
intron
N/AENSP00000500745.2P23458

Frequencies

GnomAD3 genomes
AF:
0.140
AC:
21284
AN:
152114
Hom.:
1784
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.215
Gnomad AMI
AF:
0.0954
Gnomad AMR
AF:
0.131
Gnomad ASJ
AF:
0.0879
Gnomad EAS
AF:
0.301
Gnomad SAS
AF:
0.156
Gnomad FIN
AF:
0.105
Gnomad MID
AF:
0.158
Gnomad NFE
AF:
0.0918
Gnomad OTH
AF:
0.136
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.140
AC:
21320
AN:
152232
Hom.:
1784
Cov.:
32
AF XY:
0.142
AC XY:
10570
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.215
AC:
8914
AN:
41510
American (AMR)
AF:
0.131
AC:
2005
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0879
AC:
305
AN:
3470
East Asian (EAS)
AF:
0.300
AC:
1555
AN:
5176
South Asian (SAS)
AF:
0.157
AC:
755
AN:
4822
European-Finnish (FIN)
AF:
0.105
AC:
1112
AN:
10614
Middle Eastern (MID)
AF:
0.153
AC:
45
AN:
294
European-Non Finnish (NFE)
AF:
0.0918
AC:
6248
AN:
68024
Other (OTH)
AF:
0.139
AC:
294
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
921
1842
2764
3685
4606
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
224
448
672
896
1120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.117
Hom.:
1327
Bravo
AF:
0.148
Asia WGS
AF:
0.219
AC:
758
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.037
DANN
Benign
0.20
PhyloP100
-4.4

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs578481; hg19: chr1-65528755; API